Recently, it has been described that human fertility is associated with the interleukin 10 (IL10) À2849 AA genotype. Preeclampsia is the most common pregnancy-specific complication. In the pathogenesis of pre-eclampsia, IL10 may affect maternal intravascular inflammation as well as endothelial dysfunction. Therefore, we tested the hypothesis that pre-eclampsia is associated with genetic variation in the IL10 promoter region in a case-control study for pre-eclampsia. Women homozygous for the IL10 -2849A allele have a threefold reduced risk for pre-eclampsia compared to controls (odds ratio 0.29; 95% CI 0.10-0.83). No differences in genotype frequency were found for polymorphisms in the IL10 promoter region at positions À1082, À819 and À592. This suggests that there is a genetically determined mechanism which protects the mother against preeclampsia, as reflected in the lower frequency of the IL10 -2849AA genotype in pre-eclamptic women.
Successful pregnancy is related to genetically determined defense mechanisms of the mother. One of the cytokines involved in the defense system is interleukin (IL) 10 . Comparison between unrelated individuals, and between di-and monozygotic twins have demonstrated that the interindividual differences in IL10 production are caused by genetic factors in about 70% of cases. 1 In two different studies, it has been demonstrated that blood cells from healthy persons with the IL10 -2849AA genotype 2, 3 have a significantly lower IL10 response upon stimulation with endotoxin than those with the AG and GG genotypes.
In normal pregnancy, it is still unclear as to what mechanisms prevent the fetus from being rejected by the maternal immune system and what maternal mechanisms play a role in being undisturbed by the fetus. The fetus is a semi-allograft because half of its histocompatibility antigens come from the father. It has recently been proposed that successful pregnancy is partly dependent on the genetic ability of the mother to tolerate such a semi-allograft. 4 Pre-eclampsia, clinically defined by elevated blood pressure and proteinuria, is the most common pregnancy-specific complication, leading to fetal and maternal morbidity and mortality. 5 Its pathogenesis is unknown. Pre-eclampsia is associated with maternal intravascular inflammation, endothelial dysfunction, shallow invasion of spiral arteries and abnormal placentation. 6 Abnormal placentation resulting in recurrent abortion is associated with significantly lower IL10 responsiveness of the IL10 -2849AA genotype. 1 We hypothesize that genetic variation in the promoter region of the IL10 gene is one of the determinants of the maternal defense mechanism associated with abnormal placentation, resulting in pre-eclampsia. In this study, we analyzed the genetic variation in the IL10 promoter region at positions -A2849G, -G1082A, -C819T and -C592A in a case-control study for pre-eclampsia. 3, 7 Currently, the IL10 -A2849G is the best marker of IL10 production. [8] [9] [10] We found a lower frequency for the IL10 À2849A allele for women with pre-eclampsia compared to controls (Table 1) . Women homozygous for the IL10 À2849AA genotype have a threefold reduced risk for pre-eclampsia compared to control subjects (Table 1) . Logistic regression revealed that after adjustment for established risk factors of pre-eclampsia, including familial hypertension, diabetes and obesity, the presence of the A allele remains an independent protective factor. No differences between cases and controls were found in the distribution of the genotypes of the other three polymorphisms in the promoter region of the IL10 gene (-G1082A, -C819T, -C592A).
The threefold lower frequency of the IL10 À2849AA genotype in women with pre-eclampsia suggests a genetically determined protective mechanism of the mother for pre-eclampsia. The IL10 -2849AA genotype, which is associated with reduced IL10 production, 1 might protect pregnant women against developing preeclampsia. In line with this finding is the observation of Roth and Fisher 11 that IL10 is an autocrine inhibitor of cytotrophoblast invasion in the uterine wall; in in vitro studies, high IL10 concentrations reduce trophoblast invasion. Reduced cytotrophoblast invasion in the uterine wall is an important feature in the pathogenesis of pre-eclampsia. In contrast, in studies using immunohistochemistry, diminished IL-10 in the villous trophoblast was found in pre-eclampsia. 12 Moreover, the physiological significance of circulating levels of IL10 in pre-eclampsia remains unclear:
13 the inability to consistently detect IL10 in maternal serum in normal and complicated pregnancies, despite using highly sensitive assays, suggests that the potential use of IL10 in blood as a clinical diagnostic marker in pregnancy should be approached with caution.
14 Our data suggest that IL10 might play an important role in the pathogenesis of pre-eclampsia locally, early in pregnancy rather than reflecting the maternal syndrome clinically characterized by hypertension and proteinuria late in pregnancy.
In conclusion, we found that women with preeclampsia in their first pregnancy have a threefold lower frequency of the IL10 -2849AA genotype, suggesting the existence of a genetically determined mechanism of the mother, which protects against pre-eclampsia. Women were recruited from the obstetric clinics of the Leiden University Medical Center (n ¼ 96 per group) and the St Joseph Hospital Veldhoven (n ¼ 61 per group), as has previously been described. 6 The study protocol was approved by the local Ethics Review Board. Data were analyzed anonymously. The presence of the four different polymorphisms in the IL10 promotor region (C-592A, C-819T, G-1082A, A-2849G) were determined by PCR amplification using the following primers: C-592A /a) gatcataagg). The -592A, À819C, À1082G and -2849G alleles corresponded to digested PCR products of 240 bp (two fragments), 294 and 65 bp, 318 and 42 bp, and 241 and 44 bp, respectively, whereas the À592C, À819T, À1082A and À2849A alleles corresponded to undigested PCR products of 480, 359, 360 and 285 bp, respectively. The details are described elsewhere. 3 Odds ratios were calculated as estimates of the relative risks by simple cross-tabulation for the IL10 promoter alleles at positions -A2849G, -G1082A, -C819T, -C592A and unconditional logistic regression techniques were used to allow adjustments for risk factors of pre-eclampsia simultaneously; CI ¼ confidence interval.
